Court junks Sanofi, Zuellig bid to dismiss Dengvaxia raps

More from author

BI chief reports ‘exodus’ of 2 million foreign nationals from January to September

AROUND 2 million foreign nationals were forced to leave the country this year due to the Covid-19...

DOJ indicts 8, but clears 40 in Maguindanao massacre case

THE Department of Justice (DOJ) has indicted eight more individuals in the 2009 Maguindanao massacre case...

Exercise power to tax fairly, uniformly, SC reminds govt

THE Supreme Court has reminded the government to exercise its power of taxation fairly and uniformly as...

THE Regional Trial Court (RTC) of Quezon City has denied the motions filed by the officers of Sanofi Pasteur Inc. (SPI)  and Zuellig Pharma Corp. seeking the dismissal of the damage suit filed against them over the deaths of children inoculated with the controversial Dengvaxia vaccine.

A resolution issued by QC RTC Branch 226 Presiding Judge Manuel Sta. Cruz Jr., held that the complaint filed by the heirs of Abbie Hedia sufficiently state a cause of action against the officers of the two companies to proceed with the trial of the case.

Based on the complaint, SPI manufactured Dengvaxia vaccine despite being unsafe since it was still in the clinical trial stage.

It added that SPI failed to inform the public of the risks of the product either through safety warnings, accompanying instructions or indication on use, or product label.

The complainant claimed that even after reports of serious adverse and life-threatening reactions and deaths of Dengvaxia recipients, the company offered no assistance to its supposed victims, even by way of medical attention.

The parents of Hedia narrated that prior to her vaccination, their daughter was a healthy and active child who seldom got sick.

On the other hand, the complainants blamed Zuellig for selling Dengvaxia for mass administration despite its health risks.

“Hypothetically admitting the mentioned allegations together with other facts alleged in the complaint, the court may render a judgment upon the same,” the court ruled.

Thus, the Court directed the officers of SPI—Carlito Realuyo, Conchita Santos, Jazel Anne Calvo and Pearl Grace Cabali—to answer the damage suit within five days upon receipt of the order.

“The plaintiffs are directed to coordinate with the sheriff/process server of the Branch within 60 days from receipt of this order for service of summons to the other defendants,” the resolution read.

The Public Attorney’s Office (PAO) has filed several criminal complaints before the Department of Justice  (DOJ) and independent civil actions for damages before various Quezon City courts in connection with the Dengvaxia mess.

A  total of 860,000 people, including 830,000 children, from Metro
Manila, Calabarzon, Central Luzon and Cebu were inoculated with
Dengvaxia in 2016.

The immunization program was started during the time of then-President Benigno Aquino III  and continued by the Duterte administration before the Department of Health (DOH)  stopped the program in November 2017. This, after Sanofi Pasteur announced that, while it may be effective to prevent future dengue infections, it may pose risks to those who have had no dengue infection. The latter could suffer a severe form of the hemorrhagic disease.

In March this year, the DOJ approved the indictment of former Health Secretary Janette Garin, several officials from the DOH, the Research Institute for Tropical Medicine, Food and Drug Administration (FDA) and SPI.

The DOJ panel said it found “Garin and the other respondents to have exhibited ‘inexcusable lack of precaution and foresight’ when they facilitated, with undue haste, ‘the registration and purchase of Dengvaxia’ and used the vaccine in implementing a school-based dengue mass immunization program.”

It also said that Garin and the other respondents reportedly circumvented various regulations in the purchase of P3.5 billion worth of the anti-dengue vaccine, and this constituted proof of their reckless imprudence.

Image credits: AP/Bullit Marquez

- Advertisement -


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

- Advertisement -

More updates

SMART SOLUTIONS FOR SMARTER BUSINESS | Unleashing the fullest potential of Filipino enterprises

Cortex Enterprise Solutions was built to empower Filipino businesses to be on par with the digital...
- Advertisement -

Covid vaccine rush in China raises fears of booming black market

BEFORE a planned trip to the US, Cheng wanted to get vaccinated against Covid-19. To do so, he asked a friend working at a cold-chain logistics company in southeast China to pretend he was employed by the firm, allowing Cheng access to one of the country’s experimental shots. Cheng,...

AstraZeneca eyes extra global vaccine trial as questions mount

AstraZeneca Plc’s Covid-19 vaccine looks like it’s headed for an additional global trial as the drugmaker tries to clear up uncertainty and confusion surrounding favorable results in its current study. The company wants the new test to confirm the 90 percent efficacy rate that the shot showed in a...

Duterte OKs fiscal perks for Islamic banking investments in BARMM

DAVAO CITY—The Bangsamoro autonomous region has welcomed the approval recently by President Duterte of the Investment Priorities (IPP) Plan 2020, which include the approved incentives for Islamic banking, and also listed the other priority investment areas for the region. While the IPP mainly covers Covid-19 protective devices and medical...

Filipinos nix Christmas gifts, Netflix in worst regional slump

Christmas is usually when Ajr Gie de Guzman gives the children in her family  up to  P2,000 ($42), a traditional cash gift in the Philippines known as “aguinaldo.” But after taking a buyout from her job as a hotel sales executive amid the coronavirus crisis, there won’t be such cheer this season.
- Advertisement -

More updates

Covid vaccine rush in China raises fears of booming black market

BEFORE a planned trip to the US, Cheng wanted to get vaccinated against Covid-19. To do so,...

In case you missed it